HP reduces the inflammation of NSCLC cells by decreasing Mycoplasma pneumoniae pneumonia (MPP)-induced pro-inflammatory cytokines production through NF-κB signaling pathway inactivation [64]. Here, NFKB1 is linked to non-small cell lung carcinoma.